Reducing Risk in Global Life Sciences Supply Chains
on Feb 16, 2010
Estimates on the effects of counterfeit trade exceed two hundred billion dollars (US), and inspections across the world cost billions. Yet only a very few shipments are actually inspected. This issue has particularly impacted the vital Life Sciences Supply Chain. This article discusses some of the solutions that reduce illicit trade and ensure a safe and secure supply of pharmaceuticals.
Login or Register Here
Please login or register below (at no cost) to view this item.
Existing Members -- Login Here Please
New Members -- Register Here Please
Log in to access registrant-only research and/or to edit your account profile and preferences.